Business Wire

PA-PMI

12.9.2019 15:02:08 CEST | Business Wire | Press release

Share
PMI Study Reveals Top Productivity-Boosting AI Technologies, According to Project Managers

Project Management Institute (PMI) today released its 2019 Pulse of the Profession® In-Depth Report: AI @ Work: New Projects, New Thinking. The report, a companion piece to AI Innovators: Cracking the Code on Project Performance , explores how artificial intelligence (AI) is changing the way projects are managed and delivered globally.

As AI projects become the norm, project managers need to better understand what technologies will help them streamline and improve their AI-based project work -- or they risk being left behind. The new report highlights the top AI technologies project leaders are currently leveraging to boost project management productivity, and how to incorporate AI technologies into their overall project work.

While project leaders are tapping into AI technologies to boost project productivity and quality, unlocking AI’s full potential requires building and constantly refreshing knowledge of emerging technologies. In fact, the report finds that organizations and their project leaders will need a high Project Management Technology Quotient (PMTQ) – a way of evaluating an organization’s ability to manage and integrate technology based on the needs of the organization or the project at hand – to turn AI strategy into reality.

“In today’s increasingly project-based economy, the most forward-thinking organizations know that the success of their strategies hinges on how well they can execute projects. And the race toward AI mastery is no exception,” said Michael DePrisco, vice president of global solutions at PMI. “As we see AI technologies continue to be integrated into organizations, the research indicates that project managers, especially those with a high PMTQ, are well prepared to play an integral role in implementation.”

Of the respondents to the study, 50 percent reported a high PMTQ (Innovators) and 10 percent reported only sometimes or never practicing the principles of the PMTQ (Laggards).

A majority of both groups say their project management skills and experience are a good foundation for managing AI. But the Innovators have the upper hand: 74 percent of Innovators say they’re confident their current skill set enables them to work with AI, compared with 51 percent of Laggards.

Even more so, Innovators cite having more awareness and experience with several AI technologies, including knowledge-based systems, decision management, speech recognition, and expert systems. These respondents also report delivering better outcomes when using AI technologies, including a decreased amount of time spent on activities like monitoring progress, managing documentation, as well as activity and resource planning.

The top technologies respondents cite as enhancing productivity are:

  • Robotic process automation: Technology that mimics and automates human tasks to support corporate processes.
  • Machine learning: Technology that allows computers to learn by employing pattern detection for improved decisions in subsequent situations.
  • Reinforcement learning: A machine learning technique that enables software to learn in an interactive environment by trial and error using feedback from its own actions.

The top technologies respondents identify as increasing quality are:

  • Anti-bias solutions: Technology that automatically identifies bias in a range of AI algorithms.
  • Expert systems: Technology that emulates and mimics human intelligence, skills or behavior and usually offers expert knowledge in a particular field, topic, or skill.
  • Knowledge-based systems: Technology that understands the context of the data being processed to help problem-solve procedures and support human learning, decision making, and actions.

While it is clear AI can make a difference in value delivery, it is up to organizations and their project leaders to identify and understand which technologies can best help them achieve their specific goals and deliver long-term success.

Read more about 2019 Pulse of the Profession® In-Depth Report: AI Innovators: AI @ Work: New Projects, New Thinking. The Pulse of the Profession® In-Depth research was conducted online in June/July 2019 among 780 project management practitioners globally.

About Project Management Institute (PMI)

Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Founded in 1969, PMI delivers value for more than three million professionals working in nearly every country in the world through global advocacy, collaboration, education and research. We advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org , www.projectmanagement.com , www.facebook.com/PMInstitute and on Twitter @PMInstitute.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release

Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b

LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release

The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen

Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye